In this study, we identified a combination of 14 TFs (NOTCH3, NR5A1, WDR5, RARB, SRCAP, SMAD3, ONECUT1, PITX3, TRAF6, MTA2, JDP2, FOSL1, GLI1, MTF1) and effectively predicted RFS in GC patients using the univariate Cox proportional hazard analysis, the LASSO Cox regression analysis, and multivariate Cox proportional hazard analysis. This evidence concerns the gene MTA2 and gastric cancer.